Ziagen Related Clinical Trials
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [Active, not recruiting]
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [Completed]
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) [Active, not recruiting]
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients [Active, not recruiting]
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]
Abacavir Pharmacokinetic Study [Recruiting]
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89 [Completed]
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women [Active, not recruiting]
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects [Completed]
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents [Completed]
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Completed]
A Study of 1592U89 in HIV-Infected Children [Completed]
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz [Completed]
A Study of 1592U89 in HIV-Infected Patients [Completed]
A Study of 1592U89 in HIV-Infected Adults [Completed]
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [Completed]
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC [Completed]
Blood Levels of Abacavir in HIV Infected Adolescents [Completed]
The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children [Completed]
A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs [Completed]
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients [Completed]
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex [Completed]
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Suspended]
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [Completed]
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs [Active, not recruiting]
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [Completed]
Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment [Terminated]
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors [Completed]
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs [Completed]
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. [Completed]
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen [Completed]
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients [Completed]
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Completed]
To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir. [Completed]
A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [Completed]
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE) [Recruiting]
HLA-B*5701 And Hypersensitivity To Abacavir [Completed]
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Active, not recruiting]
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue [Completed]
Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir [Recruiting]
Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. [Completed]
A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients [Completed]
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Active, not recruiting]
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Active, not recruiting]
Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-Infected Patients [Not yet recruiting]
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Active, not recruiting]
Pharmacokinetic Study Of EPZICOM Tablet [Completed]
Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination [Completed]
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [Completed]
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Completed]
Drug Interactions Among Anti-HIV Agents [Completed]
A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study [Recruiting]
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure [Completed]
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects [Recruiting]
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya [Recruiting]
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients [Completed]
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment [Completed]
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir [Recruiting]
Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [Completed]
The Effect of Teaching HIV-Infected Patients About HIV and Treatment [Completed]
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir [Completed]
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [Active, not recruiting]
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
Once-Daily Drug Regimen for HIV-Infected Patients [Completed]
Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection [Active, not recruiting]
A Study of a Combination of Four Drugs in Patients With Recent HIV Infection [Completed]
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV [Active, not recruiting]
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects [Completed]
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection [Completed]
Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya [Recruiting]
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients [Completed]
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy [Active, not recruiting]
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients [Completed]
Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. [Terminated]
Safety and Efficacy Study of Switching From Epzicom to Truvada [Recruiting]
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. [Completed]
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) [Recruiting]
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial [Recruiting]
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy [No longer recruiting]
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [Completed]
Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [Completed]
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]
A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment [Completed]
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication [Terminated]
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients [No longer recruiting]
Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs [Completed]
Increasing HAART-Induced Immune Restoration With Cyclosporine [Completed]
Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study [Recruiting]
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens [Not yet recruiting]
Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [Completed]
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection [Not yet recruiting]
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV [Recruiting]
A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701 [Not yet recruiting]
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV [Active, not recruiting]
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) [Active, not recruiting]
Sex, Aging and Antiretroviral Pharmacokinetics [Recruiting]
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults [Recruiting]
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [Active, not recruiting]
|
